NA

Neeraj Agarwal

Active Director Director DIN 01879969
DIN 01879969 First appointment Nov 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Nov 2007
Shareholding value •••• Premium profile

About Neeraj Agarwal

Data last updated:

Neeraj Agarwal is a Director at Ashley Pharmatech Private Limited (since 2015), Director at Elder Orgichem Private Limited (since 2021) and Director at Cadiz Pharmaceuticals Private Limited (since 2010). The companies operate in Pharma, Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹21.92 Cr; the largest is Ashley Pharmatech Private Limited at ₹15.88 Cr (FY 2024). Earlier, Neeraj Agarwal was a Director at Panacea Orgichem Private Limited (2021–2025) and Designated Partner at Frederick Healthcare Llp (2022–2024) and 3 more.

DIN 01879969
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 2007
Oldest Company Age 16 yrs
Largest company Ashley Pharmatech Private Limited · ₹15.88 Cr (FY 2024)
Combined revenue ₹21.92 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ashley Pharmatech Private Limited U24230DL2010PTC202596
Director06 Jun 20152010₹15.88 Cr (FY 2024)Active
Elder Orgichem Private Limited U74999DL2021PTC387934
Director07 Oct 20212021₹6.04 Cr (FY 2024)Active
Director18 Oct 20102010Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panacea Orgichem Private Limited U74999DL2021PTC387739
Director05 Oct 20212021Active
Designated Partner26 Jul 20222022Active
Director19 Feb 20102008₹16.34 Cr (FY 2025)Active
Parth Orgichem Private Limited U24100UP2013PTC061565
Director15 Feb 20182013₹3.89 Cr (FY 2021)Active
Staywell Formulation Private Limited U24233DL2007PTC170595
Director20 Nov 20072007₹3.5 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Neeraj Agarwal

Directorship timeline

Open interactive timeline →
Ashley Pharmatech Private Limited
Cadiz Pharmaceuticals Private Limited
Elder Orgichem Private Limited
Panacea Orgichem Private Limited
Premium access

Shareholding and investment profile for Neeraj Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Agarwal

Neeraj Agarwal currently holds 3 directorships: Ashley Pharmatech Private Limited (Director, since 06 Jun 2015, revenue ₹15.88 Cr (FY 2024)); Elder Orgichem Private Limited (Director, since 07 Oct 2021, revenue ₹6.04 Cr (FY 2024)); Cadiz Pharmaceuticals Private Limited (Director, since 18 Oct 2010).

Neeraj Agarwal was first appointed on 20 Nov 2007 as Director at Staywell Formulation Private Limited. The most recent appointment on record is 26 Jul 2022 at Frederick Healthcare Llp.

The 2 current companies of Neeraj Agarwal that report revenue have a combined latest revenue of ₹21.92 Cr: Ashley Pharmatech Private Limited ₹15.88 Cr (FY 2024); Elder Orgichem Private Limited ₹6.04 Cr (FY 2024).

Neeraj Agarwal held 5 earlier board appointments: Panacea Orgichem Private Limited (Director, 05 Oct 2021 to 02 Aug 2025); Frederick Healthcare Llp (Designated Partner, 26 Jul 2022 to 01 Apr 2024); Nutra Life Healthcare Private Limited (Director, 19 Feb 2010 to 15 Dec 2012); Parth Orgichem Private Limited (Director, 15 Feb 2018 to 05 Apr 2022); Staywell Formulation Private Limited (Director, 20 Nov 2007 to 15 Dec 2012).

The current boards of Neeraj Agarwal's companies include Aryan Agarwal (Ashley Pharmatech Private Limited), Zubair Ahmad (Cadiz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available